Inventor
FLEMING PAUL E
US29 patents
⚠️ This page may combine multiple inventors who share the name “FLEMING PAUL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILLENNIUM PHARM INC
18 patentsUS7732444B2Jun 8, 2010
2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
MILLENNIUM PHARM INC25 citations88
US9290500B2Mar 22, 2016
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC10 citations82
US7951801B2May 31, 2011
Beta-carbolines useful for treating inflammatory disease
MILLENNIUM PHARM INC11 citations81
US8030517B2Oct 4, 2011
CCR9 inhibitors and methods of use thereof
MILLENNIUM PHARM INC6 citations72
US7999109B2Aug 16, 2011
CCR9 inhibitors and methods of use thereof
MILLENNIUM PHARM INC4 citations72
US10202373B2Feb 12, 2019
Heteroaryls and uses thereof
MILLENNIUM PHARM INC2 citations71
US9802960B2Oct 31, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC4 citations71
US9751854B2Sep 5, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC3 citations71
US9663525B2May 30, 2017
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC1 citations58
US10035811B2Jul 31, 2018
Derivatives of 1-amino-2-cyclobutylethylboronic acid
MILLENNIUM PHARM INC0 citations52
US9771381B2Sep 26, 2017
Derivatives of 1-amino-2-cyclobutylethylboronic acid
MILLENNIUM PHARM INC0 citations52
US9023832B2May 5, 2015
Derivatives of 1-amino-2-cyclopropylethylboronic acid
MILLENNIUM PHARM INC0 citations52
US8703743B2Apr 22, 2014
Derivatives of 1-amino-2-cyclopropylethylboronic acid
MILLENNIUM PHARM INC0 citations52
US9035096B2May 19, 2015
CCR9 inhibitors and methods of use thereof
MILLENNIUM PHARM INC0 citations51
US10538533B2Jan 21, 2020
Heteroaryls and uses thereof
MILLENNIUM PHARM INC0 citations50
US10202389B2Feb 12, 2019
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50
US9796725B2Oct 24, 2017
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50
US7727985B2Jun 1, 2010
Beta-carbolines useful for treating inflammatory disease
MILLENNIUM PHARM INC0 citations37
BLUEPRINT MEDICINES CORP
7 patentsUS10202365B2Feb 12, 2019
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP20 citations94
US10233186B2Mar 19, 2019
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP16 citations93
US10227329B2Mar 12, 2019
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP19 citations85
US10774070B2Sep 15, 2020
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP6 citations84
US11634422B2Apr 25, 2023
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations70
US11236086B2Feb 1, 2022
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations62
US12595265B2Apr 7, 2026
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP0 citations59
FLEMING PAUL E
4 patentsUS8569543B2Oct 29, 2013
CCR9 inhibitors and methods of use thereof
FLEMING PAUL E1 citations60
US8664200B2Mar 4, 2014
Derivatives of 1-amino-2-cyclobutylethylboronic acid
FLEMING PAUL E0 citations50
US8513218B2Aug 20, 2013
Derivatives of 1-amino-2-cyclopropylethylboronic acid
FLEMING PAUL E1 citations50
US8268822B2Sep 18, 2012
2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
FLEMING PAUL E0 citations45